Abivax S.A.
ABVX | NASDAQ
$103.34
-$1.70 (-1.62%)
Sep 21, 2026, 11:16 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -24.68 | -2.52 | -2.82 | -2.44 | -2.65 | -2.59 |
PEG Ratio | -0.37 | 0.14 | -0.36 | -0.16 | -0.53 | -0.59 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 1.54K |
PB Ratio | 17.54 | 10.98 | 2.13 | 20.59 | 4.35 | 5.43 |
P/FCF Ratio | -51.21 | -2.88 | -4.16 | -2.73 | -2.50 | -3.16 |
P/OCF Ratio | -51.25 | -2.89 | -4.17 | -2.74 | -2.50 | -3.26 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -47.34K |
Debt / Equity Ratio | 0.10 | 2.40 | 0.30 | 5.45 | 1.99 | 1.90 |
Quick Ratio | 8.75 | 1.84 | 3.25 | 0.70 | 2.21 | 1.94 |
Current Ratio | 8.75 | 1.84 | 3.25 | 0.70 | 2.33 | 1.94 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0 |
Interest Coverage | -8.64 | -13.92 | -9.21 | -9.34 | -11.64 | -18.43 |
Return on Equity | -73.87% | -434.26% | -75.37% | -844.90% | -163.70% | -209.78% |
Return on Assets | -57.54% | -85.88% | -45.17% | -80.40% | -38.86% | -52.67% |
Return on Invested Capital | -44.70% | -110.77% | -47.14% | -119.81% | -46.87% | -68.53% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | -53.62K% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -59.6K% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -63.69K% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -60.33K% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | -48.76K% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -60.32K% |
Add to Watchlist
Select watchlists to add or remove ABVX